MD
MiMedx Group, Inc.
MDXG · NASDAQ
$4.81 +0.31% (+$0.01)
1M +12.65%
Market Cap $701.1M
P/E Ratio 112.41x
Div. Yield -
ROE 2.61%
Bulios Fair Price
$5.78
20.2% upside
Trenutna cena
$4.81
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MDXG trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
44 /100
Fair EV/EBITDA 23.92x
P/S 1.97x
P/B 3.25x
Growth
94 /100
Growing Book val. growth 51.01%
Rev. growth 16.05%
FCF growth N/A
Profitability
48 /100
Moderate Net margin 1.76%
Op. margin 2.46%
FCF margin 11.42%
Quality
24 /100
Poor ROE 2.61%
ROA 2.22%
Asset turnover 1.26x
Debt
94 /100
Low Current ratio 5.33x
Int. coverage 7.56x
Net debt/EBITDA -5.67x
Stability
48 /100
Moderate Rev. volatility 6.63%
EPS volatility 143.90%
Profitable years 3
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MDXG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph H. Capper
Employees
808
Headquarters
Marietta
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report